Amiloidózis: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• TTR 56
• BCMA 11
• APOE 0
• SGLT2 0
• CD19 4
• MAPT 0
• CD38 0
• TNF 0
• APP 0
• BCL-2 0
• RET 0
• SNCA 0
• TREM2 0
• GPRC5D 2
• IL-1 0
• IL-6 0
• JAK 0
• LAG-3 0
• PPAR 0
• BACE1 0
• CFTR 0
• CXCR4 0
• EGFR 0
• HIF-1 0
• NRF2 0
• PARP 0
• PI3K 0
• TLR4 0
• TP53 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIA · R01

  Gene therapy using Reelin fragments in mouse brain

  Henry Ford Health + Michigan State University Health Sciences· East Lansing, Egyesült Államok· 654 111 USD awarded in fiscal year 2026· until 2031. jún.

• NIH NIA · F30

  Deciphering the roles of APOE4 and amyloid-beta in Alzheimer's disease progression

  University of California-Irvine· Irvine, Egyesült Államok· 47 896 USD awarded in fiscal year 2026· until 2029. jún.

• NIH NIA · R21

  Lysosomal dysfunction as a risk factor in Alzheimer disease

  University of Illinois at Chicago· Chicago, Egyesült Államok· 240 495 USD awarded in fiscal year 2026· until 2028. máj.

• NIH NIA · R56

  The role of CLU in molecular pathogenesis of Alzheimers disease

  Translational Genomics Research Inst· Phoenix, Egyesült Államok· 798 749 USD awarded in fiscal year 2026· until 2027. aug.

• NIH NIA · R43

  Targeting CD11c immune cells to alleviate cerebral amyloid angiopathy and amyloid-related imaging abnormality in patients with Alzheimer's disease

  Mindimmune Therapeutics, Inc.· Kingston, Egyesült Államok· 496 415 USD awarded in fiscal year 2026· until 2027. szept.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Curation, Integration, Modelling and Rational Design of Small Molecule Amyloid Inhibitors (AmyStoppers)

  Vilniaus Universitetas· Vilnius, Litvánia· EU contribution 196 976 EUR· until 2029. márc.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Unravelling the Role of Cerebral Amyloid-beta Angiopathy in Epilepsy: Inflammatory Pathways and Interneuron Dysfunction (EPICAA)

  Ludwig-Maximilians-Universitaet Muenchen· Planegg, Németország· EU contribution 217 965 EUR· until 2029. febr.

• European Commission (Horizon Europe) · HORIZON-ERC

  The Mechanisms of neuronal silencing in Alzheimer’s Disease – investigation of cellular and network mechanisms in mouse models of β-amyloidosis (MONSil-AD)

  Klinikum Der Technischen Universität München (Tum Klinikum)· Muenchen, Németország· EU contribution 1 482 666 EUR· until 2030. dec.

• European Commission (Horizon 2020) · ERC-COG

  A unified drug discovery platform for protein misfolding diseases (ProMiDis)

  Erevnitiko Kentro Vioiatrikon Epistimon Alexandros Flemingk· Vari-Athens, Görögország· EU contribution 1 972 000 EUR· until 2027. febr.

9 of 305 running projects, newest first. Listed amounts together: 226,6 M USD + 3,9 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 1
• Mendelian Randomization Analysis 1
• CRISPR-Cas Systems 3
• Gene Expression Profiling 3
• Sequence Analysis, RNA 3
• Exome Sequencing 3
• Proteomics 20
• Metabolomics 2
• Mass Spectrometry 14
• Flow Cytometry 1
• Immunohistochemistry 14
• Positron-Emission Tomography 33
• Magnetic Resonance Imaging 95
• Machine Learning 13
• Deep Learning 4
• Cohort Studies 42
• Genome-Wide Association Study 2

• Concurrent fibrinogen Aα-chain amyloidosis and AA amyloidosis in a Humboldt penguin (Spheniscus humboldti).

  Vet Res Commun, 2026. okt.

• Clinicopathologic characterization of plasma cell neoplasms with IGH::CCND3.

  Am J Clin Pathol, 2026. júl.

• Multiple Myeloma Concomitant with AL Amyloidosis: Histopathological Aspects of the Common Plasma Cell Spectrum.

  Int J Mol Sci, 2026. jún.

• Systemic amyloid A amyloidosis secondary to presumed chronic vertebral osteomyelitis and pressure ulcers in a mandrill (Mandrillus sphinx).

  J Vet Med Sci, 2026. jún.

• Belgian recommendations for tissue diagnosis of amyloidosis.

  Acta Clin Belg, 2026. ápr.

• Immunohistochemical Detection of Serum Amyloid A-Derived Amyloid Deposits in Poultry Using a Synthetic Peptide-Based Antibody.

  Avian Dis, 2026. ápr.

• Evaluating Basigin as a Potential Biomarker of Blood-Brain Barrier Dysfunction in Cerebral Amyloid Angiopathy.

  Neuropathol Appl Neurobiol, 2026. febr.

• Tissue characterization in cardiac amyloidosis: a joint consensus document by the gruppo di studio di cardiopatologia (SIAPEC) and the SIC/ANMCO Italian cardiac amyloidosis network (RIAC).

  J Cardiovasc Med (Hagerstown), 2026. jan.

• Multimodal Diagnosis of Cardiac Amyloidosis: Integrating Imaging, Histochemistry, and Proteomics of Precise Typing.

  Int J Mol Sci, 2026. jan.

• Russell Body Gastritis: Histochemical and Immunohistochemical Findings in a Series of Three Patients.

  Int J Surg Pathol, 2026. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.